LSE Equity Snapshot
COIL Weekly Equity Report
Coiled Therapeutics plc
What the company does
Coiled Therapeutics plc, a clinical-stage oncology company, develops and commercialises clinical-stage oncology therapeutics in the United Kingdom and internationally. The company's lead asset is AO-252, a first-in-class, small molecule inhibitor of TACC3, currently in a Phase I clinical trial for advanced solid tumours, including ovarian and prostate cancer. The company also offers a STAT-6 siRNA programme targeting immunology indications such as asthma, fibrosis, eczema, and allergic disease, with plans for assessment towards Phase I clinical trials. The company is based in London, United Kingdom.
What the weekly tape is saying
COIL closed the latest completed week at 10.50 GBP. The 4-week return is 31.2% and the 12-week return is 2.4%. Trend Signal is inactive, Market Dynamics is 1.06. Setup signature: Risk-first tape with a 38/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 11.06 GBP
- Vs Trend Line
- -5.1%
- Fair Value
- 37.45 GBP
- Vs Fair Value
- -72.0%
- 52W High
- 30.00 GBP
- 52W Low
- 0.95 GBP
- Drawdown
- -65.0%
- Range Position
- 32.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 9
- 52W Active Breadth
- 17.3%
- Sector Scope
- GB Healthcare
- Sector Rank
- 66 of 78
- Sector Percentile
- 15.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
GB Healthcare
- Tracked Peers
- 78
- 4W Rank
- 4 of 78
- Avg 1W
- -2.0%
- Avg 4W
- -0.2%
- Trend Breadth
- 38.5%
- Positive MD
- 55.1%
GB Biotechnology
- Tracked Peers
- 29
- 4W Rank
- 2 of 29
- Avg 1W
- -3.7%
- Avg 4W
- -0.5%
- Trend Breadth
- 37.9%
- Positive RS
- 34.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.06
- 4W MD Change
- 865.7%
- Relative Strength
- -27.93
- 4W RS Change
- 39.7%
- Expectation
- Negative
- Probability
- 39.12%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 430.3K
- 13W Average
- 1.0M
- 52W Average
- 893.4K
- Vs 13W
- 0.4x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 215.0%
- 52W Volatility
- 110.8%
- Upside Weeks
- 21
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 49.5% / -14.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- LSE
- Country
- GB
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- GBP
- Market Cap
- 46.4M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 10.50 GBP | -6.7% | 11.06 GBP | 37.45 GBP | 1.06 | -27.93 | 430.3K | Off |
| 5 Jun 2026 | 11.25 GBP | 3.2% | 11.26 GBP | 37.81 GBP | 1.00 | -22.99 | 711.5K | Off |
| 29 May 2026 | 10.90 GBP | -7.2% | 11.40 GBP | 38.16 GBP | 0.67 | -26.63 | 3.6M | Off |
| 22 May 2026 | 11.75 GBP | 46.9% | 11.66 GBP | 38.53 GBP | 0.27 | -22.39 | 3.8M | Off |
| 15 May 2026 | 8.00 GBP | 6.7% | 11.88 GBP | 38.88 GBP | -0.14 | -46.31 | 1.1M | Off |
| 8 May 2026 | 7.50 GBP | 0.0% | 12.25 GBP | 39.27 GBP | -0.33 | -50.46 | 86.7K | Off |
| 1 May 2026 | 7.50 GBP | 0.0% | 12.70 GBP | 39.65 GBP | -0.21 | -51.84 | 562.9K | Off |
| 24 Apr 2026 | 7.50 GBP | -9.1% | 13.12 GBP | 40.04 GBP | -0.30 | -52.67 | 605.4K | Off |
| 17 Apr 2026 | 8.25 GBP | -8.3% | 13.58 GBP | 40.42 GBP | -0.53 | -50.26 | 871.9K | Off |
| 10 Apr 2026 | 9.00 GBP | 5.9% | 13.89 GBP | 40.81 GBP | -0.67 | -46.37 | 1.4M | Off |
| 3 Apr 2026 | 8.50 GBP | 794.7% | 14.23 GBP | 41.20 GBP | -0.87 | -49.42 | 4.1K | Off |
| 27 Mar 2026 | 0.95 GBP | -90.7% | 14.50 GBP | 41.59 GBP | -0.99 | -94.16 | 115.6K | Off |
| 20 Mar 2026 | 10.25 GBP | 0.0% | 14.97 GBP | 42.02 GBP | -0.92 | -38.05 | 366.6K | Off |
| 13 Mar 2026 | 10.25 GBP | 5.1% | 15.04 GBP | 42.41 GBP | -0.90 | -40.91 | 526.6K | Off |